Jason Leverone
Chief Financial Officer
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | OnKure Therapeutics, Inc. (OKUR) | C.P.A. Chief Financial Officer | $444,000 | $896,167 |
| 2024 | OnKure Therapeutics, Inc. (OKUR) | C.P.A. Chief Financial Officer | $382,958 | $2,678,570 |
| 2023 | OnKure Therapeutics, Inc. (OKUR) | C.P.A. Chief Financial Officer | $346,500 | $791,947 |
| 2020 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial Officer, Treasurer, and Secretary | $365,650 | $483,020 |
| 2019 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial Officer, Treasurer, and Secretary | $355,000 | $537,807 |
| 2018 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Financial Officer | $340,000 | $824,667 |
Earnings-call appearances
-
Viridian Therapeutics, Inc.DE Q4 FY2020 Earnings Call2021-03-25
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q2 FY2020 Earnings Call2020-08-05
Viridian Therapeutics, Inc.\DE (VRDN)
-
Viridian Therapeutics, Inc.DE Q1 FY2020 Earnings Call2020-05-07
Viridian Therapeutics, Inc.\DE (VRDN)